CoreRx continues to grow in 2010, providing unsurpassed contract pharmaceutical development services to the pharma & biotech industries. This is more evident with the latest announcement of the Tampa Bay Business Journal announcement of the Fast 50 nominees.
CoreRx, Inc. announces the signing of two significant contracts in the past two weeks. These contracts involve the formulation development, analytical development and validation engineering capabilities of the CoreRx, Inc. associates. These development projects will lead into clinical manufacturing activities.